Source: Andrew Siddons and Emily Kopp, ROLL CALL, 10/6/20


The Food and Drug Administration issued long-awaited guidance Tuesday on the data it expects from drug companies seeking emergency authorization of COVID-19 vaccines, rejecting White House pressure for lower standards intended to push out vaccines quickly.  The 18-page guidance was released a day after reports suggested the White House had blocked the agency from issuing the guidelines, which are meant to engender public confidence.

For more of this story, click here.